ArticleBJU international2026
Complications following repeated ureteroscopy for UTUC: The price to pay for nephron-sparing surgery.
Article in BJU international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the safety profile of, and identify predictors of complications in patients undergoing, endoscopic conservative upper tract urothelial carcinoma (UTUC) management at a high-volume tertiary centre.
methodsWe retrospectively reviewed 67 patients treated conservatively for UTUC, undergoing a total of 268 ureteroscopy (URS) procedures (2015-2025). Complications were collected via chart review and patient interviews from the first URS to last follow-up and graded according to the Clavien-Dindo classification. Univariable logistic regression was used to assess predictors of complications and ureteral stenosis (US). Cumulative incidence plots depicted time-to-complication events. Renal function was evaluated using serial estimated glomerular filtration rate measurements and analysed through individual trajectories and locally estimated scatterplot smoothed trends.
resultsThe median number of URS per patient was three (interquartile range 2-5). At least one complication occurred in 32 patients (47%). Clavien-Dindo I-II and IIIa-b events accounted for 87% and 13% of complications, respectively. Twelve patients (18%) developed endoscopic evidence of US; of these, three (25%) were treated endoscopically and two (16%) ultimately required radical nephroureterectomy. The 5-year cumulative incidence of any and major complications (Clavien-Dindo ≥ 3) was 62% (95% confidence interval 43-75) and 14% (95% confidence interval 2-25), respectively. On univariable analysis, the number of URS was the only variable significantly associated with both any complication (odds ratio 1.41 per URS, P = 0.012) and US (odds ratio 1.20 per URS, P = 0.042). The predicted risk of US reached 22.7% after six URS. Over 50 months, mean estimated glomerular filtration rate declined by >20 mL/min/1.73 m
conclusionsConservative management of UTUC is associated with a cumulative risk of mostly low-grade complications. Prolonged endoscopic follow-up may increase the likelihood of US in a subset of patients. These findings support informed patient counselling and individualized surveillance planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.